Risk factors associated with infections in pregnant women with systemic lupus erythematosus

Detalhes bibliográficos
Autor(a) principal: Valviesse,Daniele Maia de Jesus
Data de Publicação: 2022
Outros Autores: Monteiro,Denise Leite Maia, Jésus,Nilson Ramires de, Jésus,Guilherme Ribeiro Ramires de, Santos,Flavia Cunha, Lacerda,Marcela Ignacchiti, Rodrigues,Nadia Cristina Pereira, Klumb,Evandro Mendes
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536
Resumo: SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone.
id AMB-1_27644b8be5bf0f703e1aab30ffc034ae
oai_identifier_str oai:scielo:S0104-42302022000400536
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling Risk factors associated with infections in pregnant women with systemic lupus erythematosusSystemic lupus erythematosusInfectionPregnancyRisk factorsSUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone.Associação Médica Brasileira2022-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536Revista da Associação Médica Brasileira v.68 n.4 2022reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20220074info:eu-repo/semantics/openAccessValviesse,Daniele Maia de JesusMonteiro,Denise Leite MaiaJésus,Nilson Ramires deJésus,Guilherme Ribeiro Ramires deSantos,Flavia CunhaLacerda,Marcela IgnacchitiRodrigues,Nadia Cristina PereiraKlumb,Evandro Mendeseng2022-09-13T00:00:00Zoai:scielo:S0104-42302022000400536Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2022-09-13T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv Risk factors associated with infections in pregnant women with systemic lupus erythematosus
title Risk factors associated with infections in pregnant women with systemic lupus erythematosus
spellingShingle Risk factors associated with infections in pregnant women with systemic lupus erythematosus
Valviesse,Daniele Maia de Jesus
Systemic lupus erythematosus
Infection
Pregnancy
Risk factors
title_short Risk factors associated with infections in pregnant women with systemic lupus erythematosus
title_full Risk factors associated with infections in pregnant women with systemic lupus erythematosus
title_fullStr Risk factors associated with infections in pregnant women with systemic lupus erythematosus
title_full_unstemmed Risk factors associated with infections in pregnant women with systemic lupus erythematosus
title_sort Risk factors associated with infections in pregnant women with systemic lupus erythematosus
author Valviesse,Daniele Maia de Jesus
author_facet Valviesse,Daniele Maia de Jesus
Monteiro,Denise Leite Maia
Jésus,Nilson Ramires de
Jésus,Guilherme Ribeiro Ramires de
Santos,Flavia Cunha
Lacerda,Marcela Ignacchiti
Rodrigues,Nadia Cristina Pereira
Klumb,Evandro Mendes
author_role author
author2 Monteiro,Denise Leite Maia
Jésus,Nilson Ramires de
Jésus,Guilherme Ribeiro Ramires de
Santos,Flavia Cunha
Lacerda,Marcela Ignacchiti
Rodrigues,Nadia Cristina Pereira
Klumb,Evandro Mendes
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Valviesse,Daniele Maia de Jesus
Monteiro,Denise Leite Maia
Jésus,Nilson Ramires de
Jésus,Guilherme Ribeiro Ramires de
Santos,Flavia Cunha
Lacerda,Marcela Ignacchiti
Rodrigues,Nadia Cristina Pereira
Klumb,Evandro Mendes
dc.subject.por.fl_str_mv Systemic lupus erythematosus
Infection
Pregnancy
Risk factors
topic Systemic lupus erythematosus
Infection
Pregnancy
Risk factors
description SUMMARY OBJECTIVE: The aim of this study was to analyze the occurrence and risk factors associated with infections during pregnancy in patients with systemic lupus erythematosus. METHODS: This is a retrospective cohort study using the data of pregnant women who were followed up between 2011 and 2018 at a university hospital. RESULTS: The data of 221 pregnant women with systemic lupus erythematosus were analyzed. The incidence of infections was 22.6% (50/221), with the urinary tract being the most frequent site of infection (32/221, 14.5%) followed by the respiratory tract (15/221, 6.8%). The bivariate analysis showed that active disease, hematological systemic lupus erythematosus, reduced complement, and use of prednisone ≥5 and ≥10 mg increased the chance of infection during early pregnancy (p=0.05, p=0.04, p=0.003, p=0.008, and p=0.02, respectively), while disease activity and anti-DNA positivity increased it at the end of pregnancy (p=0.03 and p=0.04, respectively). Prednisone at a dose ≥5 mg increased the chance of infection in the beginning (p=0.01) and at the end of pregnancy (p=0.008). Multivariate analysis showed that increasing the dose of prednisone from 5 to 10 mg tripled the chance of developing infections in pregnant women with lupus (p=0.02). CONCLUSION: The study showed an increased chance of infections in pregnant women with systemic lupus erythematosus and it was associated with the use of prednisone.
publishDate 2022
dc.date.none.fl_str_mv 2022-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000400536
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.20220074
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.68 n.4 2022
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212837425676288